Compare CPHI & FOFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CPHI | FOFO |
|---|---|---|
| Founded | N/A | 2017 |
| Country | China | Hong Kong |
| Employees | N/A | 14 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.3M | 29.7M |
| IPO Year | 2008 | N/A |
| Metric | CPHI | FOFO |
|---|---|---|
| Price | $0.76 | $2.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 321.3K | 64.7K |
| Earning Date | 05-11-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,144,268.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.09 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $2.30 |
| 52 Week High | $2.60 | $68.00 |
| Indicator | CPHI | FOFO |
|---|---|---|
| Relative Strength Index (RSI) | 51.74 | 32.13 |
| Support Level | $0.52 | $2.34 |
| Resistance Level | $1.87 | $5.74 |
| Average True Range (ATR) | 0.19 | 0.27 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 34.15 | 4.81 |
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their unique business and investment objectives. Its business consists of two main segments: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting, and Regulatory compliance and governance consulting.